Law360, New York (June 22, 2009) -- This guest column addresses ideas on how to avoid or live with patent exhaustion, especially for the biotechnology sector.
Patent exhaustion (also known as the "first-sale doctrine") precludes a patent owner from collecting multiple times on its patent rights.
Please see full article for more information.
Please see full publication below for more information.
